Physician Groups React to Report on Pharma Payments to Providers
Specifically addressing formal medical education scenarios, Ralston told HealthLeaders that much of the onus resides on conference organizers to be alert to conflicts of interest and "develop and enforce explicit policies that maintain complete control of program planning, content and delivery."
"Backgrounds have not always been thoroughly vetted and hopefully this information will help those offering educational content develop processes to keep this from happening in the future," he said.
Noted in the study and accompanying article published by ProPublica is that payout findings only covered seven pharmaceutical companies—including giants AstraZeneca, Eli Lilly, Merck and Pfizer—that voluntarily made physician payment information public.
These relationships are expected to come under greater scrutiny as the more than 70 drug companies operating in the United States are forced to release physician payment information by March 2013 in accordance with healthcare reform mandates.
- Reform Puts Vise Grips on Physicians
- Look Beyond Nurse-Patient Ratios
- Medicare Opt-Out a Viable Physician Strategy
- Hospital Groups Back NQF Report on Patient Sociodemographics
- NPP Demand Rising Under Value-Based Care Models
- Boston Marathon Bombing Yields Lessons for Hospitals
- Providers Lag as Consumers Set Agenda
- The Flourishing Medical Tourism Business in America
- Physicians as Economic Powerhouses and Tech Laggards
- How Physicians Can Help Ease Mental Health Provider Shortages